/PRNewswire/ Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced.
Dr. Pramod Kabra appointed as Chief Executive Officer of CPC Diagnostics, a subsidiary of Everlife Asia
10/05/2021 02:00 PM
CHENNAI, India, May 10, 2021 /PRNewswire/ CPC Diagnostics Pvt. Ltd. (“CPC”), a leading provider of In-Vitro Diagnostics (IVD) products and services in India, Sri Lanka, Nepal and Bangladesh and the Indian subsidiary of Everlife Asia (“Everlife”), has announced the appointment of Dr. Pramod Kabra as the company’s Chief Executive Officer.
Based in Chennai, Dr. Kabra will be working closely with the Everlife team and local management to accelerate growth of the company by expanding reach and product offering, delivering superior performance to our partners and improving customer experience. He brings with him over 20 years of valuable and diverse industry experience notably in the Pharmaceutical, Diagnostic, and Clinical Research segments. Prior to joining CPC, he led the Specialty Diagnostics Group at Thermo Fisher Scientific. Throughout his career,